Literature DB >> 2828850

Vaccinia virus as an expression vector.

A Piccini, M E Perkus, E Paoletti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2828850     DOI： 10.1016/0076-6879(87)53077-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  18 in total

1.  Determination of influenza virus proteins required for genome replication.

Authors:  T S Huang; P Palese; M Krystal
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

Authors:  M E Perkus; K Limbach; E Paoletti
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 3.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Expression of Drosophila Shaker potassium channels in mammalian cells infected with recombinant vaccinia virus.

Authors:  R J Leonard; A Karschin; S Jayashree-Aiyar; N Davidson; M A Tanouye; L Thomas; G Thomas; H A Lester
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens.

Authors:  J Taylor; C Edbauer; A Rey-Senelonge; J F Bouquet; E Norton; S Goebel; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1.

Authors:  K Mizuno; F J Gonzalez; S Kimura
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.

Authors:  J A Tine; V Conseil; P Delplace; C De Taisne; D Camus; E Paoletti
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes.

Authors:  Simon P Graham; Roger Pellé; Yoshikazu Honda; Duncan M Mwangi; Nyerhovwo J Tonukari; Mat Yamage; E Jane Glew; Etienne P de Villiers; Trushar Shah; Richard Bishop; Evelyne Abuya; Elias Awino; James Gachanja; Anthony E Luyai; Ferdinand Mbwika; Anthony M Muthiani; David M Ndegwa; Moses Njahira; John K Nyanjui; Fredrick O Onono; Julius Osaso; Rosemary M Saya; Claude Wildmann; Claire M Fraser; Ian Maudlin; Malcolm J Gardner; Subhash P Morzaria; Sheena Loosmore; Sarah C Gilbert; Jean-Christophe Audonnet; Pierre van der Bruggen; Vishvanath Nene; Evans L N Taracha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL.

Authors:  J Tartaglia; O Jarrett; J C Neil; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.